Robyn K. Harrell

1.1k total citations
32 papers, 769 citations indexed

About

Robyn K. Harrell is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Robyn K. Harrell has authored 32 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 7 papers in Cancer Research. Recurrent topics in Robyn K. Harrell's work include Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Robyn K. Harrell is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Robyn K. Harrell collaborates with scholars based in United States, United Kingdom and Australia. Robyn K. Harrell's co-authors include Roland L. Bassett, Colleen M. Costelloe, John E. Madewell, Osama Mawlawi, Edith M. Marom, Nancy E. Fitzgerald, Eric Rohren, A. Kevin Raymond, Peter M. Anderson and Valerae O. Lewis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Robyn K. Harrell

30 papers receiving 753 citations

Peers

Countries citing papers authored by Robyn K. Harrell

Since Specialization

Citations

This map shows the geographic impact of Robyn K. Harrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn K. Harrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn K. Harrell more than expected).

Fields of papers citing papers by Robyn K. Harrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn K. Harrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn K. Harrell. The network helps show where Robyn K. Harrell may publish in the future.

Co-authorship network of co-authors of Robyn K. Harrell

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn K. Harrell. A scholar is included among the top collaborators of Robyn K. Harrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn K. Harrell. Robyn K. Harrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RWD127 Mapping the Flow of Biomarker Testing Information, from Test Order through Impact on Treatment Decision-Making: A Case Study in Metastatic NSCLC 2023 ·Value in Health ·(unknown), Robyn K. Harrell, (unknown), (unknown), (unknown), Nicholas J. Robert	0
2	Oncology-specific Qualified Clinical Data Registry (QCDR) measures to advance cancer care and achieve Merit-Based Incentive Payment System (MIPS) performance. 2022 ·Journal of Clinical Oncology ·(unknown), Taylor Adams, Robyn K. Harrell, (unknown), Lalan S. Wilfong	2
3	Abstract P6-09-02: Vitamin D levels, triple-negative breast cancer, and geography: A retrospective analysis of a large database of oncology practices in the United-States (US) 2015 ·Cancer Research ·(unknown), Janet L. Espirito, Robyn K. Harrell, (unknown), Joyce O’Shaughnessy, Ervin H. Epstein, Debra A. Patt	1
4	Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System 2014 ·Journal of Oncology Practice ·J. Russell Hoverman, (unknown), (unknown), (unknown), Jody S. Garey, Robyn K. Harrell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Diana K. Verrilli, Marcus A. Neubauer	42
5	Vitamin D levels, triple-negative histology, and geography in breast cancer: A retrospective analysis of a large database of oncology practices in the United States. 2014 ·Journal of Clinical Oncology ·(unknown), Janet L. Espirito, Robyn K. Harrell, (unknown), Joyce O’Shaughnessy, Ervin H. Epstein, Debra A. Patt	4
6	Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: Clinical utility per sequence 2013 ·Magnetic Resonance Imaging ·Colleen M. Costelloe, John E. Madewell, Vikas Kundra, Robyn K. Harrell, Roland L. Bassett, Jingfei Ma	31
7	Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing 2012 ·Human Pathology ·(unknown), Fabrice André, Robyn K. Harrell, Roland L. Bassett, Banu Arun, (unknown), Suzette Delaloge, Michael Z. Gilcrease	3
8	Changes in recruitment to public health consultant posts and hospital consultant posts in England: potential impact on the sustainability of the public health system 2011 ·Journal of Public Health ·Robyn K. Harrell, M. Julian Caley, Dominique Allwood, Tom Fowler	0
9	Incorporation of Sentinel Lymph Node Metastasis Size Into a Nomogram Predicting Nonsentinel Lymph Node Involvement in Breast Cancer Patients With a Positive Sentinel Lymph Node 2011 ·Annals of Surgery ·Elizabeth A. Mittendorf, Kelly K. Hunt, Judy C. Boughey, Roland L. Bassett, Amy C. Degnim, Robyn K. Harrell, Min Yi, Funda Meric‐Bernstam, Merrick I. Ross, Gildy V. Babiera, Henry M. Kuerer, Rosa F. Hwang	110
10	Clinical Characteristics of Patients With Prolonged Disease-Free Survival After Primary Treatment in Advanced Ovarian Cancer 2011 ·International Journal of Gynecological Cancer ·Michael R. Milam, Robyn K. Harrell, Roland L. Bassett, Lynn P. Parker, Daniel S. Metzinger, Pedro T. Ramírez	5
11	Imaging Characteristics of Hyperfunctioning Parathyroid Adenomas Using Multiphase Multidectector Computed Tomography 2011 ·Journal of Computer Assisted Tomography ·Thinh Vu, Nandita Guha‐Thakurta, Robyn K. Harrell, Salmaan Ahmed, Ashok J. Kumar, Valen E. Johnson, Nancy D. Perrier, Leena M. Hamberg, George J. Hunter, Dawid Schellingerhout	24
12	Correlation of NRAS Mutations With Clinical Response to High-dose IL-2 in Patients With Advanced Melanoma 2011 ·Journal of Immunotherapy ·Richard W. Joseph, Ryan J. Sullivan, Robyn K. Harrell, Katherine Stemke‐Hale, David J. Panka, (unknown), Andrew Percy, Roland L. Bassett, Chaan S. Ng, Laszlo Radvanyi, Patrick Hwu, Michael B. Atkins, Michael A. Davies	86
13	Comparison of half-dose and full-dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors 2010 ·Skeletal Radiology ·Colleen M. Costelloe, William A. Murphy, Tamara Miner Haygood, Rajendra Kumar, Kevin W. McEnery, R. Jason Stafford, (unknown), Roland L. Bassett, Robyn K. Harrell, John E. Madewell	7
14	Neoadjuvant Chemotherapy Is Associated With Prolonged Primary Treatment Intervals in Patients With Advanced Epithelial Ovarian Cancer 2010 ·International Journal of Gynecological Cancer ·Michael R. Milam, Tao Xia, Robert L. Coleman, Robyn K. Harrell, Roland L. Bassett, Ricardo dos Reis, Pedro T. Ramírez	15
15	Pleomorphic Ductal Carcinoma of the Breast: Predictors of Decreased Overall Survival 2010 ·The American Journal of Surgical Pathology ·(unknown), (unknown), Kelly K. Hunt, Khazi M. Nayeemuddin, (unknown), Robyn K. Harrell, Roland L. Bassett, Michael Z. Gilcrease	12
16	Immunohistochemical detection of lymphovascular invasion with D2‐40 in melanoma correlates with sentinel lymph node status, metastasis and survival 2009 ·Journal of Cutaneous Pathology ·Fredrik Petersson, A. Hafeez Diwan, Doina Ivan, Jeffrey E. Gershenwald, Marcella M. Johnson, Robyn K. Harrell, Víctor G. Prieto	62
17	¹⁸F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma 2009 ·Journal of Nuclear Medicine ·Colleen M. Costelloe, Homer A. Macapinlac, John E. Madewell, Nancy E. Fitzgerald, Osama Mawlawi, Eric Rohren, A. Kevin Raymond, Valerae O. Lewis, Peter M. Anderson, Roland L. Bassett, Robyn K. Harrell, Edith M. Marom	143
18	Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis 2009 ·Skeletal Radiology ·Colleen M. Costelloe, A. Kevin Raymond, Nancy E. Fitzgerald, Osama Mawlawi, Rodolfo Núñez, John E. Madewell, Robyn K. Harrell, Roland L. Bassett, Edith M. Marom	10
19	Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma 2009 ·Blood ·Constantine S. Tam, Roland L. Bassett, Celina Ledesma, Martin Körbling, Amin Alousi, Chitra Hosing, (unknown), Robyn K. Harrell, Gabriela Rondón, Sergio Giralt, Paolo Anderlini, Uday Popat, Barbara Pro, Barry I. Samuels, Frederick Hagemeister, L. Jeffrey Medeiros, Richard E. Champlin, Issa F. Khouri	134
20	Addition of Rituximab to Mobilization and Conditioning Overcomes the Predictive Value of Follicular Lymphoma International Prognostic Index (FLIPI) Score in Patients with Relapsed FL Undergoing Autologous Stem Cell Transplantation (AUTO). 2008 ·Blood ·Issa F. Khouri, Roland L. Bassett, Barry I. Samuels, Farzaneh Maadani, Grace‐Julia Okoroji, Robyn K. Harrell, Martin Körbling, Leandro de Pádua Silva, Amin M. Alousi, Chitra Hosing, Sergio Giralt, Marcos de Lima, Paolo Anderlini, Uday Popat, (unknown), Yvonne Hsu, Fredrick B. Hagemeister, Peter McLaughlin, L. Jeffrey Medeiros	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact